These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19966083)

  • 1. Emergency-use authorization of peramivir.
    Gonzalez R; Massoomi F; Neff W
    Am J Health Syst Pharm; 2009 Dec; 66(24):2162-3. PubMed ID: 19966083
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
    Ison MG; Hollister AS; Sheridan WP
    Clin Infect Dis; 2013 Jan; 56(1):164. PubMed ID: 22972863
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009?
    Pavia AT
    Clin Infect Dis; 2012 Jul; 55(1):16-8. PubMed ID: 22491500
    [No Abstract]   [Full Text] [Related]  

  • 4. The emergency use authorization of peramivir IV: a view from the manufacturer.
    Hollister AS; Sheridan WP
    Clin Pharmacol Ther; 2011 Feb; 89(2):172-4. PubMed ID: 21252934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
    Birnkrant D; Cox E
    N Engl J Med; 2009 Dec; 361(23):2204-7. PubMed ID: 19884645
    [No Abstract]   [Full Text] [Related]  

  • 6. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.
    Yu Y; Garg S; Yu PA; Kim HJ; Patel A; Merlin T; Redd S; Uyeki TM
    Clin Infect Dis; 2012 Jul; 55(1):8-15. PubMed ID: 22491506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
    Arya V; Carter WW; Robertson SM
    Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emergency admission of peramivir in the U.S.A].
    Bennack E; Holzgrabe U
    Pharm Unserer Zeit; 2010; 39(1):9-10. PubMed ID: 20033965
    [No Abstract]   [Full Text] [Related]  

  • 9. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous peramivir emergency use authorization 2009: update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2010; 24(2):51-3. PubMed ID: 20168138
    [No Abstract]   [Full Text] [Related]  

  • 11. Peramivir: another tool for influenza treatment?
    Jain S; Fry AM
    Clin Infect Dis; 2011 Mar; 52(6):707-9. PubMed ID: 21367723
    [No Abstract]   [Full Text] [Related]  

  • 12. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peramivir and its use in H1N1 influenza.
    Castillo R; Holland LE; Boltz DA
    Drugs Today (Barc); 2010 Jun; 46(6):399-408. PubMed ID: 20571608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
    Sorbello A; Jones SC; Carter W; Struble K; Boucher R; Truffa M; Birnkrant D; Gada N; Camilli S; Chan I; Dallas S; Scales T; Kosko R; Thompson E; Goodman J; Francis H; Dal Pan G
    Clin Infect Dis; 2012 Jul; 55(1):1-7. PubMed ID: 22491501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W;
    Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losing the opportunity to study influenza drugs.
    Meyerhoff A; Lietman P
    JAMA; 2010 Mar; 303(9):878-9. PubMed ID: 20197536
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG; Fraiz J; Heller B; Jauregui L; Mills G; O'Riordan W; O'Neil B; Playford EG; Rolf JD; Sada-Diaz E; Elder J; Collis P; Hernandez JE; Sheridan WP
    Antivir Ther; 2014; 19(4):349-61. PubMed ID: 23985625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe immune thrombocytopenia possibly elicited by the anti-influenza viral agent peramivir.
    Harada-Shirado K; Ikeda K; Furukawa M; Sukegawa M; Takahashi H; Shichishima-Nakamura A; Ohkawara H; Noji H; Kawabata K; Saito S; Ohto H; Ogawa K; Takeishi Y
    Intern Med; 2014; 53(20):2369-71. PubMed ID: 25318805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency authorization of medical products: regulatory challenges from the 2009 H1N1 influenza pandemic in Japan.
    Urushihara H; Matsui S; Kawakami K
    Biosecur Bioterror; 2012 Dec; 10(4):372-82. PubMed ID: 23210832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.